Table 2 Sensitivity analyses by treatment group
*
|
Treatment group
|
Mean cost*
(£)
|
Mean adjusted QALYs*
|
Incremental cost effectiveness ratio to nearest £100 or comment
|
Excluding participants with health care costing more than £2000 over 12 months (n=1266)
|
|
|
|
Best care in general practice
|
277
|
0.621
|
|
Best care plus exercise
|
322
|
0.632
|
Subject to extended dominance by manipulation
|
Best care plus manipulation and exercise
|
403
|
0.647
|
Subject to extended dominance by manipulation
|
Best care plus manipulation
|
411
|
0.665
|
£3000 relative to best care
|
NHS provides manipulation for only 50% of patients (n=1287)
|
|
|
|
Best care in general practice
|
346
|
0.616
|
|
Best care plus exercise
|
486
|
0.628
|
Subject to extended dominance by manipulation and exercise
|
Best care plus manipulation and exercise
|
537
|
0.645
|
£6600 relative to best care
|
Best care plus manipulation
|
624
|
0.655
|
£8700 relative to manipulation and exercise
|
Manipulation provided only in private premises (n=1287)
|
|
|
|
Best care in general practice
|
346
|
0.616
|
|
Best care plus exercise
|
486
|
0.628
|
Subject to extended dominance by manipulation and exercise
|
Best care plus manipulation and exercise
|
595
|
0.645
|
£8600 relative to best care
|
Best care plus manipulation
|
701
|
0.655
|
£10 600 relative to manipulation and exercise
|
|
QALY=quality adjusted life year.
* Markov Chain Monte Carlo estimates from bivariate hierarchical multilevel model.
Estimated by analysis of covariance with adjustment for baseline EQ-5D score and then rounded to three significant figures.